English 
Tel: +86-531-81219803/01
Email: export@biobase.com
6th floor, No. 2 building, 9 Gangxing road, High-tech Zone, Jinan, Shandong, China
 |
Introduction:
The chemiluminescence immunoassay system usesmagnetic particle separation technology, which usesmagnetic particles as antibody carriers, which can beevenly distributed in the liquid phase reaction systemwith faster reaction speed and higher efficiency. Usingenzymatic chemiluminescence method, the light signalis more stable. A new generation of enzymatic substrateswith higher sensitivity and faster luminescence
| Quantity: | |
|---|---|
BKI1100
BIOBASE
Instrument Performance:
Technical Advantages:
Models:
Model | BKI1100 |
Throughput | 180T/H |
Principle | Magnetic particle enzymatic chemiluminescence |
Modes of Operation | Random, Batch and STAT |
Separation method | Magnetic separation technology |
Sample Positions | 60 (Each position could be used as an emergency position) |
Reagent Positions | 25 pcs (2-8℃ refrigeration) |
Incubation Positions | 58 |
Time to 1st Result | 18 Minutes |
Sample Volume | 10-200μl |
Detection Precision | CV≤5% |
Carry-over Rate | ≤10-5 |
Correlation Coefficient | r≥0.99 |
Calibration Stability | 28 Days |
Calibration Type | 6/7-point calibration |
Software system | Windows 7/8/10, 32 or 64 bit; Bi-direction, support HL7 protocol; |
Interface | TCP/IP Network interface |
Other Function | Liquid level detection |
Anti-collision function | |
Sample barcode scanning | |
Reagent radio frequency identification | |
Intelligent alarm prompt | |
Power Supply | AC220V 50/60Hz(Standard); AC110V 60Hz(Optional) |
External Size (W*D*H) | 768*771*568 |
Net Weight | 94Kg |
Package Size (WD*H) | 1303*873*854mm |
Gross Weight | 163kg |
Reagent Menu:
Thyroid | TSH;TT4;TT3;FT4;FT3;TgAb;TPOAb;TG;Anti-TSHR; CT |
Anemia | FERRITIN;VB12;FA |
Liver Fibrosis | CIV;LN;HA;PIIINP |
Hypertension | ALD;ACTH;Cortisol; Renin |
Fertility | β-HCG;E2;P;T;PRL;FSH; LH;DHEA-S;SHBG;AMH |
Growth | GH |
Bone Metabolism | BGP; 25-OH-Vit-D; iPTH;BGP |
Tumor Marker | CA125;CA15-3;CA199;AFP;CEA; t-PSA; f-PSA |
Pepsinogen | PGI;PGII |
Kidney Function | β2-MG |
Rheumatism | Anti-CCp |
Diabetes | C-P;INS |
ardiac Marker | cTnl; CK-MB;MYO; NT-proBNP |
lnflammation | PCT;IL-β |
Instrument Performance:Technical Advantages:
Models:
Model | BKI1100 |
Throughput | 180T/H |
Principle | Magnetic particle enzymatic chemiluminescence |
Modes of Operation | Random, Batch and STAT |
Separation method | Magnetic separation technology |
Sample Positions | 60 (Each position could be used as an emergency position) |
Reagent Positions | 25 pcs (2-8℃ refrigeration) |
Incubation Positions | 58 |
Time to 1st Result | 18 Minutes |
Sample Volume | 10-200μl |
Detection Precision | CV≤5% |
Carry-over Rate | ≤10-5 |
Correlation Coefficient | r≥0.99 |
Calibration Stability | 28 Days |
Calibration Type | 6/7-point calibration |
Software system | Windows 7/8/10, 32 or 64 bit; Bi-direction, support HL7 protocol; |
Interface | TCP/IP Network interface |
Other Function | Liquid level detection |
Anti-collision function | |
Sample barcode scanning | |
Reagent radio frequency identification | |
Intelligent alarm prompt | |
Power Supply | AC220V 50/60Hz(Standard); AC110V 60Hz(Optional) |
External Size (W*D*H) | 768*771*568 |
Net Weight | 94Kg |
Package Size (WD*H) | 1303*873*854mm |
Gross Weight | 163kg |
Reagent Menu:
Thyroid | TSH;TT4;TT3;FT4;FT3;TgAb;TPOAb;TG;Anti-TSHR; CT |
Anemia | FERRITIN;VB12;FA |
Liver Fibrosis | CIV;LN;HA;PIIINP |
Hypertension | ALD;ACTH;Cortisol; Renin |
Fertility | β-HCG;E2;P;T;PRL;FSH; LH;DHEA-S;SHBG;AMH |
Growth | GH |
Bone Metabolism | BGP; 25-OH-Vit-D; iPTH;BGP |
Tumor Marker | CA125;CA15-3;CA199;AFP;CEA; t-PSA; f-PSA |
Pepsinogen | PGI;PGII |
Kidney Function | β2-MG |
Rheumatism | Anti-CCp |
Diabetes | C-P;INS |
ardiac Marker | cTnl; CK-MB;MYO; NT-proBNP |
lnflammation | PCT;IL-β |
